Dr. Michael Pellini is a Managing Partner at Section 32 and Chairman of Foundation Medicine. He previously served as the Chief Executive Officer at Foundation Medicine from 2011 until February 2017. Prior to this he served as Chief Operating Officer at PLUS Diagnostics and was President and Chief Operating Officer at Clarient. He also served as Vice President of Life Sciences at Safeguard Scientifics, Inc. Michael serves as Director and Scientific Advisory Board Member at Cira Discovery Sciences, Chairman of Foundation Medicine and is currently on the boards of Veneti, Adaptive Biotechnologies, Tango Therapeutics and Singular Genomics and The Personalized Medicine Coalition. Michael holds a Medical Degree from Jefferson Medical College of Thomas Jefferson University in Philadelphia, an MBA Degree from Drexel University in Philadelphia and a BA in Economics from Boston College in Massachusetts.